Calumet Specialty Prods (NASDAQ:CLMT) reported quarterly losses of $(1.18) per share which missed the analyst consensus estimate of $(0.58) by 103.45 percent. This is a 195.16 percent decrease over earnings of $1.24 per share from the same period last year. The company reported quarterly sales of $1.100 billion which beat the analyst consensus estimate of $972.117 million by 13.16 percent. This is a 4.26 percent decrease over sales of $1.149 billion the same period last year.
Calumet Specialty Prods Q3 2024 GAAP EPS $(1.18) Misses $(0.58) Estimate, Sales $1.100B Beat $972.117M Estimate
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.